Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Frameworks for transformational breakthroughs in RNA-based medicines
JR Androsavich - Nature Reviews Drug Discovery, 2024 - nature.com
RNA has sparked a revolution in modern medicine, with the potential to transform the way
we treat diseases. Recent regulatory approvals, hundreds of new clinical trials, the …
we treat diseases. Recent regulatory approvals, hundreds of new clinical trials, the …
Advances in the design and delivery of RNA vaccines for infectious diseases
RNA medicines represent a paradigm shift in treatment and prevention of critical diseases of
global significance, eg, infectious diseases. The highly successful messenger RNA (mRNA) …
global significance, eg, infectious diseases. The highly successful messenger RNA (mRNA) …
Advanced technologies for the development of infectious disease vaccines
Vaccines play a critical role in the prevention of life-threatening infectious disease. However,
the development of effective vaccines against many immune-evading pathogens such as …
the development of effective vaccines against many immune-evading pathogens such as …
The Epidemiology of COVID‐19 Vaccine‐Induced Myocarditis
C Costa, F Moniati - Advances in Medicine, 2024 - Wiley Online Library
Background. In December 2019, the emergence of severe acute respiratory syndrome
coronavirus‐2 (SARS‐CoV‐2) led to the COVID‐19 pandemic, with millions of deaths …
coronavirus‐2 (SARS‐CoV‐2) led to the COVID‐19 pandemic, with millions of deaths …
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine
Abstract Background Group A Streptococcus (Strep A) causes both uncomplicated and
severe invasive infections, as well as the post-infection complications acute rheumatic fever …
severe invasive infections, as well as the post-infection complications acute rheumatic fever …
[HTML][HTML] Influence of Mutations on Physicochemical Properties of Spike Proteins from Prototypical SARS-CoV-2 Variants of Concern Detected in Amazonian Countries
ACB Silva, CAM Carvalho - Microbiology Research, 2024 - mdpi.com
Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the viral spike protein (S) has become a target to describe appropriate epitopes for vaccine …
the viral spike protein (S) has become a target to describe appropriate epitopes for vaccine …
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
The highly pathogenic coronaviruses SARS-CoV-2 and SARS-CoV have led to the COVID-
19 pandemic and SARS outbreak, respectively. The receptor-binding domain (RBD) of the …
19 pandemic and SARS outbreak, respectively. The receptor-binding domain (RBD) of the …
Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA Vaccine
S Chalkias, A Pragalos, A Akinsola… - The Journal of …, 2025 - academic.oup.com
Background mRNA-1283 is an investigational coronavirus disease 2019 (COVID-19) mRNA
vaccine encoding the receptor-binding and N-terminal domains of the severe acute …
vaccine encoding the receptor-binding and N-terminal domains of the severe acute …
In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition
G Mahalingam, S Marepally - Molecular Therapy, 2024 - cell.com
In a world grappling with the evolving variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), another emerging respiratory virus, respiratory syncytial virus …
coronavirus 2 (SARS-CoV-2), another emerging respiratory virus, respiratory syncytial virus …
mRNA Vaccines: Future Perspectives for Children
The introduction of messenger ribonucleic acid (mRNA) vaccine technology represents a
significant breakthrough in immunology and public health, offering a novel approach to …
significant breakthrough in immunology and public health, offering a novel approach to …